|
|
||||||||









* Institute for Biomedical EngineeringCell Biology, University Medical School Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany;
Max Delbrück Center for Molecular Medicine, Berlin, Germany;
Department of Biochemistry, Christian Albrechts University, Kiel, Germany; and
Institute of Medical Radiation and Cell Research, University of Wurzburg, Wurzburg, Germany
Dendritic cells (DC) represent key regulators of the immune system, yet their development from hemopoietic precursors is poorly defined. In this study, we describe an in vitro system for amplification of a Flt3+CD11b+ progenitor from mouse bone marrow with specific cytokines. Such progenitor cells develop into both CD11b+ and CD11b DC, and CD8
+ and CD8
DC in vivo. Furthermore, with GM-CSF, these progenitors synchronously differentiated into fully functional DC in vitro. This two-step culture system yields homogeneous populations of Flt3+CD11b+ progenitor cells in high numbers and allows monitoring the consecutive steps of DC development in vitro under well-defined conditions. We used phenotypic and functional markers and transcriptional profiling by DNA microarrays to study the Flt3+CD11b+ progenitor and differentiated DC. We report here on an extensive analysis of the surface Ag expression of Flt3+CD11b+ progenitor cells and relate that to surface Ag expression of hemopoietic stem cells. Flt3+CD11b+ progenitors studied exhibit a broad overlap of surface Ags with stem cells and express several stem cell Ags such as Flt3, IL-6R, c-kit/SCF receptor, and CD93/AA4.1, CD133/AC133, and CD49f/integrin
6. Thus, Flt3+CD11b+ progenitors express several stem cell surface Ags and develop into both CD11b+ and CD11b DC, and CD8
+ and CD8
DC in vivo, and thus into both of the main conventional DC subtypes.
This article has been cited by other articles:
![]() |
D. Ruau, R. Ensenat-Waser, T. C. Dinger, D. S. Vallabhapurapu, A. Rolletschek, C. Hacker, T. Hieronymus, A. M. Wobus, A. M. Muller, and M. Zenke Pluripotency Associated Genes Are Reactivated by Chromatin-Modifying Agents in Neurosphere Cells Stem Cells, April 1, 2008; 26(4): 920 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis J. Immunol., October 15, 2007; 179(8): 5228 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Niki, H. Takaishi, J. Takito, T. Miyamoto, N. Kosaki, H. Matsumoto, Y. Toyama, and N. Tada Administration of Cyclooxygenase-2 Inhibitor Reduces Joint Inflammation but Exacerbates Osteopenia in IL-1{alpha} Transgenic Mice Due to GM-CSF Overproduction J. Immunol., July 1, 2007; 179(1): 639 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Despars and H. C. O'Neill Splenic endothelial cell lines support development of dendritic cells from bone marrow. Stem Cells, June 1, 2006; 24(6): 1496 - 1504. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |